EUDA Health Holdings Limited (EUDA)vsPrologis Inc (PLD)
EUDA
EUDA Health Holdings Limited
$14.53
+0.28%
REAL ESTATE · Cap: $20.08M
PLD
Prologis Inc
$138.82
+2.31%
REAL ESTATE · Cap: $132.47B
Smart Verdict
WallStSmart Research — data-driven comparison
Prologis Inc generates 181597% more annual revenue ($9.38B vs $5.16M). PLD leads profitability with a 39.7% profit margin vs 5.2%. EUDA trades at a lower P/E of 26.6x. PLD earns a higher WallStSmart Score of 63/100 (C+).
EUDA
Avoid31
out of 100
Grade: F
PLD
Buy63
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for EUDA.
Margin of Safety
+48.3%
Fair Value
$268.84
Current Price
$138.82
$130.02 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 60.2% year-over-year
Conservative balance sheet, low leverage
Keeps 40 of every $100 in revenue as profit
Strong operational efficiency at 38.5%
Earnings expanding 65.2% YoY
Large-cap with strong market position
Reasonable price relative to book value
Areas to Watch
Moderate valuation
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Premium valuation, high expectations priced in
ROE of 6.8% — below average capital efficiency
Expensive relative to growth rate
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EUDA
The strongest argument for EUDA centers on Revenue Growth, Debt/Equity. Revenue growth of 60.2% demonstrates continued momentum.
Bull Case : PLD
The strongest argument for PLD centers on Profit Margin, Operating Margin, EPS Growth. Profitability is solid with margins at 39.7% and operating margin at 38.5%.
Bear Case : EUDA
The primary concerns for EUDA are P/E Ratio, EPS Growth, Market Cap.
Bear Case : PLD
The primary concerns for PLD are P/E Ratio, Return on Equity, PEG Ratio.
Key Dynamics to Monitor
EUDA profiles as a hypergrowth stock while PLD is a mature play — different risk/reward profiles.
PLD carries more volatility with a beta of 1.41 — expect wider price swings.
EUDA is growing revenue faster at 60.2% — sustainability is the question.
EUDA generates stronger free cash flow (-3M), providing more financial flexibility.
Bottom Line
PLD scores higher overall (63/100 vs 31/100), backed by strong 39.7% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
EUDA Health Holdings Limited
REAL ESTATE · REAL ESTATE SERVICES · USA
EUDA Health Holdings Limited is a biopharmaceutical innovator dedicated to the discovery, development, and commercialization of transformative therapies addressing rare diseases and unmet medical needs. Leveraging cutting-edge technologies and a robust clinical pipeline, the company focuses on pivotal areas such as supportive care and immune modulation. With a strong commitment to research and development, EUDA is poised to advance healthcare innovation and enhance patient outcomes, while striving to broaden access to essential medical therapies through its promising clinical initiatives.
Visit Website →Prologis Inc
REAL ESTATE · REIT - INDUSTRIAL · USA
Prologis, Inc. is a real estate investment trust headquartered in San Francisco, California that invests in logistics facilities, with a focus on the consumption side of the global supply chain.
Compare with Other REAL ESTATE SERVICES Stocks
Want to dig deeper into these stocks?